The transatlantic healthcare landscape presents a complex tapestry of diverse models to cancer care. While both the United States and Europe boast remarkable advancements in oncology, significant variations exist in their respective architectures. This article delves into these gaps, exploring the factors shaping them and highlighting potential ave